360° SearchNetwork Hot Spots Trends Time Series

Advanced Search Options >>

Diamyd Medical AB

Type: Company

Name: Diamyd Medical AB

Nationality: Sweden

Web Address: http://www.diamyd.com

Fact Sheet: Fact Sheet for Diamyd Medical AB

First reported May 20 2013 - Updated May 20 2013 - 2 reports

Nasdaq OMX Group Inc

NASDAQ OMX Welcomes Diamyd Medical to First North

NASDAQ OMX (NASDAQ: NDAQ) announces that the trading in Diamyd Medical AB (short name: DMYD B) shares commenced today on First North at NASDAQ OMX Stockholm. Diamyd Medical belongs to the Healthcare sector and is the eighth new company to be admitted ... [Published Bobsguide - May 20 2013]

Entities: Diamyd Medical AB, Nasdaq OMX Group Inc, Diabetes

First reported May 17 2013 - Updated May 17 2013 - 1 reports

Chairman increases holdings in Diamyd

The Chairman of Diamyd Medical, Anders Essen-M$ller, has today bought 1,429,656 shares in Diamyd Medical and his holdings in Diamyd Medical amounts after the transaction to 479,292 series A-shares and 1,617,397 series B-shares, representing approximately ... [Published Noodls - May 17 2013]

Entities: Diamyd Medical AB, Diabetes, Peter Zerhouni

First reported May 17 2013 - Updated May 17 2013 - 1 reports

Diamyd Medical AB

DIAMYD MEDICAL AB: Chairman increases holdings in Diamyd

Diamyd Medical is a Swedish diabetes company. The company was formerly called Diamyd Therapeutics and was spun off from Mertiva AB (formerly Diamyd Medical) in April 2013. The company's primary development project consists of the GAD-based diabetes vaccine ... [Published 4 Traders - May 17 2013]

Entities: Diamyd Medical AB, Diabetes Type I, Diabetes

First reported May 17 2013 - Updated May 17 2013 - 1 reports

Chairman increases holdings in Diamyd (Diamyd Medical AB)

The Chairman of Diamyd Medical, Anders Essen-Möller, has today bought 1,429,656 shares in Diamyd Medical and his holdings in Diamyd Medical amounts after the transaction to 479,292 series A-shares and 1,617,397 series B-shares, representing approximately ... [Published Presscontacts.com - May 17 2013]

Entities: Diamyd Medical AB, Diabetes Type I, Diabetes

First reported May 15 2013 - Updated May 15 2013 - 3 reports

New Diamyd Medical listed on NASDAQ OMX First North on May 20, 2013 (Diamyd Medical AB)

Diabetes has developed into a major global problem. The disorder is affecting younger and younger people and complications related to diabetes are currently among the most common causes of death in many countries. In conjunction with the spin-out of the ... [Published Presscontacts.com - May 15 2013]

Entities: Diamyd Medical AB, Diabetes, Diabetes Type I, Vaccine

First reported May 14 2013 - Updated May 14 2013 - 1 reports

Diamyd broadens the diabetes portfolio

You are now entering the website of Diamyd Medical AB, former Diamyd Therapeutics AB, which on April 22, 2013 was spun out from the former parent company Diamyd Medical AB, now renamed Mertiva AB.Mertiva shares are listed on NASDAQ OMX (segment Small ... [Published Diamyd Medical - May 14 2013]

Entities: Diamyd Medical AB, Therapeutics, Diabetes, Nasdaq OMX Group Inc

First reported May 14 2013 - Updated May 14 2013 - 2 reports

Diamyd broadens the diabetes portfolio

Diamyd Medical has concluded a new exclusive licensing agreement with the University of California in Los Angeles (UCLA) relating to a patent portfolio for the therapeutic use of GABA (gamma-aminobutyric acid) in connection with type 1 diabetes and other ... [Published Noodls - May 14 2013]

Entities: Diamyd Medical AB, Diabetes, Diabetes Type I, Vaccine, Rheumatoid Arthritis

First reported May 14 2013 - Updated May 14 2013 - 1 reports

Market Report, "Diamyd Medical AB - Product Pipeline Review - 2013", published

(live-PR.com) - Global Market Direct's pharmaceuticals report, "Diamyd Medical AB - Product Pipeline Review - 2013" provides data on the Diamyd Medical AB's research and development focus. The report includes information on current developmental pipeline, ... [Published Live-PR.com - May 14 2013]

Entities: Diamyd Medical AB, Pipeline, Chronic Pain, Diabetes, Research & Development

First reported May 03 2013 - Updated May 03 2013 - 2 reports

Walgreens April Sales Increase 3.8 Percent

DEERFIELD, Ill. - (BUSINESS WIRE) - Walgreens (NYSE: WAG) (Nasdaq: WAG) had April sales of $5.98 billion, an increase of 3.8 percent from $5.76 billion for the same month in fiscal 2012.Total front-end sales decreased 2.9 percent compared with the same ... [Published NewsBlaze - May 03 2013]

Entities: Walgreen Co, Doubletree, Diamyd Medical AB

First reported May 03 2013 - Updated May 03 2013 - 1 reports

Diamyd Medical AB – Product Pipeline Review – 2013

SummaryGlobal Market Direct’s pharmaceuticals report, “Diamyd Medical AB - Product Pipeline Review - 2013” provides data on the Diamyd Medical AB’s research and development focus. The report includes information on current developmental pipeline, complete ... [Published MarketResearch.com - May 03 2013]

Entities: Diamyd Medical AB, Pipeline, Research & Development, modality, Drugs

First reported Apr 22 2013 - Updated Apr 23 2013 - 6 reports

Diamyd Medical Changes Name to Mertiva

STOCKHOLM - (BUSINESS WIRE) - Regulatory News:Mertiva AB (STO:DIAM-B)(Pink Sheets:DMYDY):At an Extraordinary General Meeting of Diamyd Medical AB on April 22, 2013, it was decided to change the Company's name to Mertiva AB. The web address to Mertiva ... [Published NewsBlaze - Apr 23 2013]

Entities: Diamyd Medical AB, Business Analytics, Atlantic Coast Bank, Bond Street Holdings Inc

First reported Apr 23 2013 - Updated Apr 23 2013 - 1 reports

Diamyd spins out the subsidiary Diamyd Therapeutics which changes name to Diamyd Medical

Entities: Diamyd Medical AB, Therapeutics, Nasdaq OMX Group Inc, Stockholm, OTCQX

Quotes

"We welcome Diamyd Medical to First North, one of Europe's most liquid growth markets," says Adam Kostyal, Senior Vice President at NASDAQ OMX. "We've experienced a marked inflow of life science companies and Diamyd is our fourth addition to the healthcare sector this year."

NASDAQ OMX Nordic: NASDAQ OMX WELCOMES DIAMYD MEDICAL TO FIRST NORTH [Published FinanzNachrichten.de - May 20 2013]

"Our intention is to test Diamyd® both in combination with other drugs to boost the beta cell preserving effect displayed by the diabetes vaccine, but also as a preventative treatment to try to stop the onset of type 1 diabetes and other autoimmune diabetes altogether" says Peter Zerhouni

New Diamyd Medical listed on NASDAQ OMX First North on May 20, 2013 (Diamyd Medical AB) [Published Presscontacts.com - May 15 2013]

"Our intention is to test Diamyd$ The dominating hypothesis among diabetes reers today is that the key to curing type 1 diabetes is to simultaneously tackle the disease on several fronts by combining various therapeutics or by providing treatment before onset of the disease. Combination therapies have, for example, played a decisive role in the advances made in cancer treatment in recent years. Many leading scientists also believe that future treatment of type 1 diabetes must involve a so called autoantigen, such as GAD, which is the active substance in the diabetes vaccine, Diamyd$ Reer-initiated trials"

New Diamyd Medical listed on NASDAQ OMX First North on May 20, 2013 [Published Noodls - May 15 2013]

...that lets you create fully formed objects in your home or small business," said Mike Edwards, Staples executive vice president, merchandising. "Staples is known for carrying the latest technology and 3D printers are the most recent example of our commitment to offering every product your business needs to succeed."

Staples First Major U.S. Retailer to Announce Availability of 3D Printers [Published NewsBlaze - May 03 2013]

More Content

sort by: Date \| Relevance
Stockholm Business Region: Exclusive Showcase a... [Published Business Wire - May 21 2013]
Exclusive showcase at BioEquity Europe 2013 in ... [Published MyNewsDesk - May 21 2013]
NASDAQ OMX Welcomes Diamyd Medical to First North [Published Bobsguide - May 20 2013]
NASDAQ OMX Nordic: NASDAQ OMX WELCOMES DIAMYD M... [Published FinanzNachrichten.de - May 20 2013]
NASDAQ OMX WELCOMES DIAMYD MEDICAL TO FIRST NORTH [Published GlobeNewswire: Advertising News - May 20 2013]
Chairman increases holdings in Diamyd [Published Noodls - May 17 2013]
DIAMYD MEDICAL AB: Chairman increases holdings ... [Published 4 Traders - May 17 2013]
Chairman increases holdings in Diamyd (Diamyd M... [Published Presscontacts.com - May 17 2013]
New Diamyd Medical listed on NASDAQ OMX First N... [Published Presscontacts.com - May 15 2013]
DIAMYD MEDICAL AB : New Diamyd Medical listed o... [Published 4 Traders - May 15 2013]
New Diamyd Medical listed on NASDAQ OMX First N... [Published Noodls - May 15 2013]
Diamyd broadens the diabetes portfolio [Published Diamyd Medical - May 14 2013]
Diamyd broadens the diabetes portfolio [Published Noodls - May 14 2013]
DIAMYD MEDICAL AB : Diamyd broadens the diabete... [Published 4 Traders - May 14 2013]
Diamyd broadens the diabetes portfolio [Published CisionWire - English - May 14 2013]
Market Report, "Diamyd Medical AB - Product Pip... [Published Live-PR.com - May 14 2013]
"Chronic Pain - Pipeline Review, H1 2013" Publi... [Published Live-PR.com - May 07 2013]
Abby F. Kohnstamm Joins Pitney Bowes as Chief M... [Published NewsBlaze - May 03 2013]
Walgreens April Sales Increase 3.8 Percent [Published NewsBlaze - May 03 2013]
Superior Industries Reports Financial Results f... [Published NewsBlaze - May 03 2013]
Staples First Major U.S. Retailer to Announce A... [Published NewsBlaze - May 03 2013]
Belden's Reliable Signal Transmissions Ensure t... [Published NewsBlaze - May 03 2013]
Mertiva, tidigare Diamyd Medical, noteras på Na... [Published GlobeNewswire: Advertising News - May 03 2013]
Mertiva, former Diamyd Medical, will be listed ... [Published GlobeNewswire: Advertising News - May 03 2013]
Applied Materials to Hold Q2 FY2013 Earnings Ca... [Published NewsBlaze - May 03 2013]
American Centrifuge Achieves Two RD&D Program M... [Published NewsBlaze - May 03 2013]
TearScience Dry Eye Treatment Featured on The D... [Published NewsBlaze - May 03 2013]
Mertiva AB: Mertiva, former Diamyd Medical, wil... [Published Business Wire Professional Services News - May 03 2013]
Mertiva, former Diamyd Medical, will be listed ... [Published CisionWire - English - May 03 2013]
Diamyd Medical AB – Product Pipeline Review – 2013 [Published MarketResearch.com - May 03 2013]

Press Releases

sort by: Date \| Relevance
Stockholm Business Region: Exclusive Showcase a... [Published Business Wire - May 21 2013]
NASDAQ OMX WELCOMES DIAMYD MEDICAL TO FIRST NORTH [Published GlobeNewswire: Advertising News - May 20 2013]
Diamyd broadens the diabetes portfolio [Published CisionWire - English - May 14 2013]
Mertiva, tidigare Diamyd Medical, noteras på Na... [Published GlobeNewswire: Advertising News - May 03 2013]
Mertiva, former Diamyd Medical, will be listed ... [Published GlobeNewswire: Advertising News - May 03 2013]